Abstract: This application provides a method and device for detecting charging abnormality, and a storage medium. In this application, a first sampling moment corresponding to a first minimum voltage in n sampled voltages is determined based on n consecutive sampled voltages of a first cell from an end moment of an ith charging phase to an end moment of an (i+1)th charging phase in a kth charging process. A second sampling moment corresponding to a second minimum voltage in any one of the first (k?1)th charging processes can be determined in the same way. Then abnormality of the kth charging process is determined.

Abstract: A system and a method for squaring a ingot are provided, the system for squaring a ingot, including: a squaring chamber configured to remove cut edges of the ingot; and a movement stage disposed at one side of the squaring chamber in a first direction, wherein the movement stage is provided with a loading mechanism and a unloading mechanism, the loading mechanism and the unloading mechanism are respectively arranged on two sides of the movement stage opposite to each other in a second direction different from the first direction, and while the unloading mechanism collects the cut edges and removes the ingot after removal of the cut edges, the loading mechanism is configured to transport another ingot to be squared to the squaring chamber.

Abstract: Embodiments of this application relate to the technical field of batteries, and in particular, to a state-of-charge cut-off control method, apparatus and system, and a storage medium. The method includes: obtaining, in a discharging process of a battery, a net discharge capacity of a first battery cell from being fully charged to current time; obtaining an available capacity and a state of health of the first battery cell; obtaining a current remaining dischargeable capacity of the first battery cell; and setting a state of charge SOC of the first battery cell to 0.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Various implementations disclosed herein include devices, systems, and methods that generate floorplans and measurements using a three-dimensional (3D) representation of a physical environment generated based on sensor data.

Abstract: Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.

Abstract: Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.

Abstract: Embodiments are provided for network resource allocation considering user experience, satisfaction, and operator interest. An embodiment method by a network component for allocating network resources includes evaluating, for a user, a QoE for each flow of a plurality of flows in network traffic in according with a QoE model, and further evaluating, for an operator, a revenue associated with the flows in accordance with a revenue model. A plurality of priorities that correspond to the flows are calculated in accordance with the QoE for the user and the revenue for the operator. The method further includes identifying a flow of the flows with a highest value of the priorities, and allocating a network resource for the flow. In an embodiment, the QoE model is a satisfaction model that provides a measure of user satisfaction for each flow in accordance with a subscription or behavior class of the user.

Abstract: An enhanced virus detection monitoring (VDM) system and method suitable for use with network systems, and in particular electronic document control systems (EDCS) is disclosed. The VDM system intercepts files and documents before they are made available to other users (“check-in”) and inspects the files/documents for virus infection. If a virus infection is found in a file or document, the VDM system invokes anti-virus software to disinfect the file or document. Once the virus has been removed from the file or document, the file (or document) is then made available to other users of the system. If the virus cannot be removed, the file (or document) is not allowed to be checked-in.